I

Inland Northwest Research | Spokane, WA

Research site
(Unclaimed)
Location
610 South Sherman Street, Suite 20, Spokane, Washington, United States of America

Site insights

Top conditions

Top treatments

ABBV-951
TD-9855
Carbidopa
Levodopa
Buntanetap
BIIB122
SEP-363856
Neflamapimod
NE3107
ABBV-0805

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 38 total trials

A Study of TAK-341 in Treatment of Multiple System Atrophy

The main aim is to see how TAK-341 works after 52 weeks in participants with multiple system atrophy as measured by the Unified Multiple System Atrop...

Enrolling
Multiple System Atrophy
Drug: Placebo
Drug: TAK-341

In this study, researchers will learn more about a study drug called BIIB122 in participants with early-stage Parkinson's disease (PD). In this study...

Enrolling
Parkinson Disease
Drug: BIIB122
Drug: BIIB122-Matching Placebo

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab...

Active, not recruiting
Parkinsons Disease
Drug: Prasinezumab
Drug: Placebo

The primary objective of this study is to evaluate the safety and tolerability of single and multiple doses of BIIB094 administered via intrathecal (...

Active, not recruiting
Parkinson's Disease
Drug: Placebo
Drug: BIIB094

The purpose of this randomized, double-blind, placebo-controlled study is to assess the efficacy of BIA 28-6156 over placebo in delaying clinical mea...

Enrolling
Parkinson's Disease
Drug: Placebo
Drug: BIA 28-6156 60 mg

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot fr...

Active, not recruiting
Parkinson's Disease (PD)
Drug: ABBV-951

This study will evaluate the safety, biomarkers, and efficacy of tominersen compared with placebo in participants with prodromal and early manifest H...

Enrolling
Huntington Disease
Drug: Tominersen 60 mg
Drug: Placebo

This is a double-blinded, controlled, randomized clinical trial (RCT) to establish the safety and efficacy of a non-invasive neuromodulation device f...

Enrolling
Parkinson Disease
Parkinson's Disease and Parkinsonism
Device: Non-invasive brainstem stimulation

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot fr...

Active, not recruiting
Parkinson's Disease (PD)
Drug: ABBV-951

Trial sponsors

AbbVie logo
Biogen logo
Theravance Biopharma logo
Abbott logo
Acadia Pharmaceuticals logo
A
Roche logo
Takeda logo
A
Athira Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems